<scp>C</scp>4d‐negative antibody‐mediated rejection with high anti‐angiotensin <scp>II</scp> type <scp>I</scp> receptor antibodies in absence of donor‐specific antibodies

Abstract

These cases support the routine assessment of anti-AT1 R antibodies in kidney transplant recipients to identify subjects at risk. Further studies will need to determine optimal assessment protocol and the effectiveness of pre-emptive treatment with angiotensin receptor blockers.